Retinal vein occlusion disease and platelet activation: will antiplatelet therapy be a promising therapeutic strategy for patients with retinal vein occlusion disease in the future?

Thromb Haemost. 2007 Feb;97(2):169-70.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Blood Platelets / drug effects*
  • Blood Platelets / metabolism
  • Collagen / pharmacology
  • Humans
  • Platelet Activation / drug effects*
  • Platelet Aggregation Inhibitors / pharmacology
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Function Tests
  • Retinal Vein Occlusion / blood
  • Retinal Vein Occlusion / drug therapy*
  • Retinal Vein Occlusion / metabolism
  • Signal Transduction / drug effects

Substances

  • Platelet Aggregation Inhibitors
  • Collagen